Candidate: I have faculty appointments in Nutrition and Dietetics at Saint Louis University and in Internal Medicine at Washington University. My education focused on exercise physiology and I have experience with clinical trials involving diet and exercise. My career goal is to perform independent research on the roles of exercise and nutrition in the prevention and management of diabetes and cardiovascular disease. The K01 Award will help me achieve this goal by providing support while I undergo the following training: I will learn how to perform frequently sampled oral glucose tolerance tests and "incretin effect" tests;I will learn how to conduct outpatient feedings as a dietary intervention;I will undergo training in data management, grant writing, grantsmanship, and responsible conduct in research;and, I will attend and present at scientific symposia and meetings. ENVIRONMENT: My affiliations with two universities will provide an excellent setting for my career development. At Saint Louis University I will grow as a dietetics researcher, as the environment is rich with dietetics experts and has the infrastructure that is necessary for conducting outpatient feedings. At Washington University, I have access to excellent facilities for performing metabolic tests and have strong working relationships with several experienced scientists who will provide their guidance and expertise. RESEARCH PLAN: I will conduct a randomized trail to assess the hypothesis that weight losses induced by caloric restriction (CR) and by exercise (EX) improve glucose tolerance and insulin action through partly distinct mechanisms and that the benefits from CR and EX are additive. To assess this hypothesis, glucoregulation will be assessed in 60 overweight, middle-aged men and women before and after 6% weight loss induced by 10-14 weeks of CR, EX, or CR+EX. Additional testing will be performed to explore candidate mechanisms for the improvements in glucoregulation.

Public Health Relevance

The study findings may have implications for the prevention and management of hyperglycemia and insulin resistance, both of which are risk factors for type 2 diabetes. It is expected that greater health benefits can be obtained by using both caloric restriction and exercise than can be obtained from either treatment alone. Additionally, the findings may demonstrate that some of the benefits of caloric restriction are not attributable to weight loss, per se, and this may shed new light on the mechanisms involved in long-term blood sugar control.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Scientist Development Award - Research & Training (K01)
Project #
Application #
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Podskalny, Judith M,
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Saint Louis University
Schools of Allied Health Profes
Saint Louis
United States
Zip Code
Weiss, Edward P; Royer, Nathaniel K; Fisher, Jonathan S et al. (2014) Postprandial plasma incretin hormones in exercise-trained versus untrained subjects. Med Sci Sports Exerc 46:1098-103
Kahle, Laura E; Kelly, Patrick V; Eliot, Kathrin A et al. (2013) Acute sodium bicarbonate loading has negligible effects on resting and exercise blood pressure but causes gastrointestinal distress. Nutr Res 33:479-86
Murphy, Joan C; McDaniel, Jennifer L; Mora, Katherine et al. (2012) Preferential reductions in intermuscular and visceral adipose tissue with exercise-induced weight loss compared with calorie restriction. J Appl Physiol (1985) 112:79-85
Niekamp, Katherine; Zavorsky, Gerald S; Fontana, Luigi et al. (2012) Systemic acid load from the diet affects maximal-exercise RER. Med Sci Sports Exerc 44:709-15
Weiss, Edward P; Fontana, Luigi (2011) Caloric restriction: powerful protection for the aging heart and vasculature. Am J Physiol Heart Circ Physiol 301:H1205-19
Weiss, Edward P; Villareal, Dennis T; Fontana, Luigi et al. (2011) Dehydroepiandrosterone (DHEA) replacement decreases insulin resistance and lowers inflammatory cytokines in aging humans. Aging (Albany NY) 3:533-42